Recently, down regulation of PAR-4 in transgenic mouse models of mammary tumorigenesis and in breast cancer patients was identified as an important mechanism of tumour cell survival and recurrence at both local and distant sites following chemotherapy and targeted therapy21. This evidence concerns the gene PAWR and neoplasm.